See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct. 13, 2003

Epilepsy (Pediatric) Breast Cancer Multiple Sclerosis

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Epilepsy (Pediatric)

A study to evaluate the effectiveness and tolerability of an investigational medication in pediatric patients with inadequately-controlled partial seizures. Volunteers 1 to 23 months old who have a diagnosis of partial seizures may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat473.html.

-----

Breast Cancer

A study of a combination of medications in patients with locally advanced and/or metastatic breast cancer. Volunteers who have experienced no improvement within six weeks of last dose of anthracycline-based chemotherapy and whose disease has been stable after administration of a minimum of four cycles of anthracycline-based chemotherapy may be eligible. Research site located in Indianapolis, Indiana.

More Information

Please see http://www.centerwatch.com/patient/studies/cat29.html.

-----

Multiple Sclerosis

A study to establish the safety and effectiveness of a combination of medications for multiple sclerosis. Volunteers 18 to 55 who have a documented diagnosis of relapsing-remitting multiple sclerosis and have been treated with Interferon Beta-1a injections for at least six months but less than four years may be eligible to participate. Research site located in Kansas City, Kansas.

More Information

Please see http://www.centerwatch.com/patient/studies/cat102.html.

-----

Copyright 2003 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.